European Companies Search Engine
EU funding (€186,167): Activation of mitochondria during embryogenesis Hor 9 Apr 2020 EU Research and Innovation programme "Horizon"
Overview
Text
Activation of mitochondria during embryogenesis
Mitochondria are well known as the powerhouse of cells and play a vital role in embryo development regulating energy homeostasis. Mitochondrial function has been studied for decades, although several aspects of mitochondrial metabolism during development still remain unclear. Which mechanisms are responsible for the continuous increase in respiratory chain activity during embryogenesis? How does translational activity in the early embryo contribute to this process, and how is the translational activity in mitochondria coordinated with the translational activity in the cytoplasm? In my project, I will investigate mechanisms that underlie the increase in mitochondrial energy production during embryogenesis. Using zebrafish embryos as a model system for vertebrate development, I propose to measure mitochondrial translational activity with de novo translation assays and assess its contribution to the assembly of new respiratory chain complexes. Also, I will explore the largely enigmatic mechanism of the co-regulation of cytoplasmic and mitochondrial translation. My research will provide novel insights into the universal yet poorly understood mechanisms that activate mitochondrial function after fertilization. Since in the early embryo nucleus is transcriptionally inactive, my work has the potential to discover novel, transcription-independent feedback-mechanisms that balance mitochondrial and cytoplasmic translations.
Funded Companies:
| Company name | Funding amount |
| Forschungsinstitut FUR Molekulare Pathologie GmbH | €186,167 |
Source: https://cordis.europa.eu/project/id/895790
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Forschungsinstitut für molekulare Pathologie GmbH, Vienna, Austria.